Assessment of risk factors for cardiovasuclar disease in pediatric renal transplant patients

Pediatric Transplantation

Volumn 11, Issue 7, 2007, Pages 721-729

  Silverstein, Douglas M ^a,b   Mitchell, Miranda ^b   LeBlanc, Pamela ^a   Boudreaux, J Philip ^b  

^a CHILDREN S HOSPITAL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular; Renal; Risk factors; Transplant

Indexed keywords

HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; LIPID BLOOD LEVEL; ORGAN DONOR; PEDIATRICS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BLOOD PRESSURE; CADAVER; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TISSUE DONORS;

EID: 34848908786     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00730.x     Document Type: Article

References (39)

1. Mistnefes MM. Pediatric end-stage renal disease: Heart as a target. J Pediatr 2002 : 141 : 162 164.
2. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 2000 : 14 : 105 110.
3. Mitsnefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 2002 : 7 : 535 539.
4. Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: Blood pressure and allograft function. Pediatr Transplant 2001 : 5 : 160 165.
5. Greenspan LC, Gitelman SE, Leung MA, Glidden DV, Mathias RS. Increased incidence of post-transplant diabetes mellitus in children: A case-control analysis. Pediatr Nephrol 2002 : 17 : 1 5.
6. Dharnidharka VR, Harmon WE. Management of pediatric postrenal transplantation infections. Semin Nephrol 2001 : 21 : 521 531.
7. Melter M, Briscoe DM. Challenges after pediatric transplantation. Semin Nephrol 2000 : 20 : 199 208.
8. Matsuda-Abedini M, Portale AA, Shah A, Neuhaus J, McEnhill M, Mathias RS. Persistent secondary hyperparathyroidism after renal transplantation in children. Pediatr Nephrol 2006 : 21 : 413 418.
9. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998 : 9 : s16 s23.
10. Parekh RS, Carrol CE, Wolfe RA, Port FK. Cardiovascular death in children and young adults with end-stage kidney disease. J Pediatr 2002 : 141 : 191 197.
11. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 1999 : 56 : 1566 1570.
12. Mann JFE, Gerstein HC, Dulau-florea I, Lonn E. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int 2003 : 63 (S84 S192 196.
13. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation-a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 1994 : 8 : 570 573.
14. Ibels LS, Alfrey AC, Weil R III. Hyperlipidemia in adults, pediatric, and diabetic renal transplant recipients. Am J Med 1978 : 64 : 634 642.
15. Saldanha LF, Hurst KS, Amend WJ Jr., et al. Hyperlipidemia after renal transplantation in children. Am J Dis Child 1976 : 130 : 951S 953S.
16. Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE. Hyperlipidemia in long-term survivors of pediatric renal transplantation. Clin Transplant 1994 : 8 : 252 257.
17. Aldamiz-Echevarria L, Sanjuro P, Vallo A, et al. Hyperhomocysteinemia in children with renal transplants. Pediatr Nephrol 2002 : 17 : 718 723.
18. Perfumo F, Canepa A, Divino-Filho JC, et al. Muscle and plasma amino acids and nutritional status in kidney transplanted children. Nephrol Dial Transplant 1994 : 9 : 1778 1785.
19. Yorgin PD, Belson A, Sanchez J, et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002 : 40 : 1306 1318.
20. Johnstone LM, Jones CL, Grigg LE, Wilkjinson JL, Walker RG, Powell HR. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 1996 : 50 : 998 1006.
21. Sarwal MM, Vidhun JR, Alexander SR, et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003 : 76 : 1331 1339.
22. Silverstein DM, Aviles DH, Leblanc PM, Jung FF, Vehaskari VM. Results of one year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 2005 : 9 : 162 169.
23. National high blood pressure education program working group on high blood pressure in children and adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004 : 114 (2 Suppl. 4th Report 555.
24. K/DOQI. Clinical Practice Guidelines for chronic kidney diseases: Evaluation, classification, and stratification. Am J Kidney Dis 2002 : 39 (Suppl. 1 S17 S21.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 : 27 : S5 S10.
26. Wuhl E, Hadtstein C, Mehls O, Schaefer F, Escape trial group. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 2004 : 55 : 492 497.
27. Querfeld U. Disturbances of lipid metabolism in children with chronic renal failure. Pediatr Nephrol 1993 : 7 : 749 757.
28. Poyrazoglu HM, Dusunsel R, Narin F, et al. Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatr Nephrol 2004 : 19 : 193 198.
29. Eschbach JW, Funk DD, Adamson J. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989 : 35 : 134 148.
30. Mak RH, Cheung W. Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 2006 : 21 : 1807 1814.
31. Mak RH, Haycock G, Chantler C. Glucose intolerance in children with chronic renal failure. Kidney Int 1993 : 15 (Suppl) : S22 S26.
32. Höcker B, John U, Plank C, et al. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years. Transplantation 2004 : 78 : 228 234.
33. Ribes D, Kamar N, Esposito L, Rostaing L. Combined use of tacrolimus and sirolimus in de novo renal transplant patients: Current data. Transpl Proc 2005 : 37 : 2813 2816.
34. Gonwa T, Mendez R, Vang HC, Weisntein S, Jensik S, Steinberg S. Prograf study group: Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. Transplantation 2003 : 75 : 1213 1220.
35. Almeida M, Martins LS, Dias L, et al. Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients. Transpl Proc 2005 : 37 : 2777 2780.
36. Morrisett JD, Abdel-Fattah G, Hoogeveen R, et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res 2002 : 43 : 1170 1180.
37. Romero F, Rodríguez-Iturbe B, Pons H, et al. Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit. Atherosclerosis 2002 : 152 : 127 133.
38. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002 : 39 : 695 701.
39. Sorof JM. Ambulatory blood pressure monitoring in pediatric end-stage renal disease: Chronic dialysis and transplantation. Blood Press Monit 1999 : 4 : 171 174.